This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
A recent study in the journal PNAS from the lab of Julie Overbaugh reveals a previously unknown antiviral function of a gene ...
Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...
Bispecific antibodies bring multiple tumor-cell-killing mechanisms into play simultaneously. When a T cell is activated and ...
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) is attracting investor attention: Here is what you should know
CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company's CRISPR-based ...
The global pest control industry is steering towards a whopping $32.8 billion valuation by 2028, growing at a compound annual ...
India's GenAI infrastructure is being built, but can a public-private partnership outpace the trillion-dollar budgets of US ...
Data Demonstrate Potent in vivo Gene Editing of Hematopoietic Stem Cells (HSCs) in the Bone Marrow with Systemic Delivery in Preclinical Murine ...
Merck , known as MSD outside the United States and Canada, announced today that the province of Saskatchewan has added CAPVAXIVE®, a 21-valent pneumococcal conjugate vaccine, to its publicly funded ...
Modern Engineering Marvels on MSN
CRISPRi unveils tuberculosis’ fatal respiratory weak point
A disease that has stalked humanity for millennia may have finally met its match. Mycobacterium tuberculosis, the pathogen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results